Back to Search
SAMIA BABAR, MD
MD
Internal Medicine Physician
NPI: 1720266281IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
D0067075(MD)
CMS Specialties
PrimaryHOSPITALIST
Education
OTHER
Class of 2002
Research & Publications (20)
Effects of phosphodiesterase inhibitors on the inflammatory response of endothelial cells stimulated by myeloperoxidase-modified low-density lipoprotein or tumor necrosis factor alpha.
PMID 19185976·Eur Urol·2010
8-other
Effects of oxygen therapy on systemic inflammation and myeloperoxidase modified LDL in hypoxemic COPD patients.
PMID 19230893·Atherosclerosis·2009
8-other
Development and validation of a screening procedure for the assessment of inhibition using a recombinant enzyme.
PMID 18371913·Talanta·2008
4-observational
Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification.
PMID 18063373·Bioorg Med Chem·2008
8-other
CE at the omics level: towards systems biology--an update.
PMID 18040991·Electrophoresis·2008
6-review
Synovial and tenosynovial lipoma arborescens of the ankle in an adult: a case report.
PMID 17968542·Skeletal Radiol·2008
5-case
Measurement of phosphorylated phospholamban levels in cardiomyocytes (HL-1) by immunoprecipitation.
PMID 17590443·J Biochem Biophys Methods·2008
8-other
MRI demonstration of the effect of neoadjuvant radiotherapy on rectal carcinoma.
PMID 17851843·Acta Oncol·2007
3-trial
Human 5-HT transporter availability predicts amygdala reactivity in vivo.
PMID 17715358·J Neurosci·2007
8-other
Experimental design optimization of the capillary electrophoresis separation of leucine enkephalin and its immune complex.
PMID 17688300·J Sep Sci·2007
8-other
Inhibition of the myeloperoxidase chlorinating activity by non-steroidal anti-inflammatory drugs: flufenamic acid and its 5-chloro-derivative directly interact with a recombinant human myeloperoxidase to inhibit the synthesis of hypochlorous acid.
PMID 17610876·Eur J Pharmacol·2007
8-other
Is serum galectin-3 a potential predictor of the response to active specific immunotherapy in melanoma patients?
PMID 17243984·J Eur Acad Dermatol Venereol·2007
8-other
Probucol does not inhibit myeloperoxidase-dependent low-density lipoprotein oxidation as a potent protective effect in atherosclerosis.
PMID 17878766·J Cardiovasc Pharmacol·2007
8-other
Triggering of inflammatory response by myeloperoxidase-oxidized LDL.
PMID 17167545·Biochem Cell Biol·2006
4-observational
Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
PMID 16631159·Eur J Pharmacol·2006
4-observational
The pleiotropic effect of statins in haemodialysis patients is not the consequence of an inhibition of LDL oxidation by myeloperoxidase.
PMID 16574674·Nephrol Dial Transplant·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6701 N CHARLES ST
TOWSON, MD 21204 - Phone
- (443) 849-8046
Quick Facts
- NPI
- 1720266281
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile